The DOI matches its Crossref record; 126 of the 129 references it cites were found in a registry or an index.
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
Open accessAbstract
OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently available; this could accelerate and facilitate OA drug discovery and development programs. The goal of this document is to provide a summary and guide to the application of in vitro (biochemical and other soluble) biomarkers in the development of drugs for OA and to outline and stimulate a research agenda that will further this goal. METHODS: The Biomarkers Working Group representing experts in the field of OA biomarker research from both academia and industry developed this consensus document between 2007 and 2009 at the behest of the Osteoarthritis Research Society International Federal Drug Administration initiative (OARSI FDA initiative). RESULTS: This document summarizes definitions and classification systems for biomarkers, the current outcome measures used in OA clinical trials, applications and potential utility of biomarkers for development of OA therapeutics, the current state of qualification of OA-related biomarkers, pathways for biomarker qualification, critical needs to advance the use of biomarkers for drug development, recommendations regarding practices and clinical trials, and a research agenda to advance the science of OA-related biomarkers. CONCLUSIONS: Although many OA-related biomarkers are currently available they exist in various states of qualification and validation. The biomarkers that are likely to have the earliest beneficial impact on clinical trials fall into two general categories, those that will allow targeting of subjects most likely to either respond and/or progress (prognostic value) within a reasonable and manageable time frame for a clinical study (for instance within 1-2 years for an OA trial), and those that provide early feedback for preclinical decision-making and for trial organizers that a drug is having the desired biochemical effect. As in vitro biomarkers are increasingly investigated in the context of specific drug treatments, advances in the field can be expected that will lead to rapid expansion of the list of available biomarkers with increasing understanding of the molecular processes that they represent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By synthesizing information from circulating biomarkers, synovial fluid analysis, quantitative imaging parameters, and clinical evaluation, an integrated framework can help facilitate holistic orthopedic care and enable clinicians to detect disease earlier, stratify patients according to disease subtypes, predict progression trajectories, and monitor therapeutic responses with greater precision [9”
From Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiological Assessment of Osteo-Arthrosis
Kellgren, J., & Lawrence, J. S. (1957) · Annals of the Rheumatic Diseases · doi:10.1136/ard.16.4.494 · Cited by 12,472
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Feldman, D. P., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340502 · Cited by 2,631
Abraham, J. M. (2010) · Brill | Nijhoff eBooks · doi:10.1163/ej.9789004163300.i-1081.897 · Cited by 2,612
Altman, R. D., Alarcón, G. S., Appelrouth, D. J., Bloch, D. A., BORENSTEIN, D. G., Brandt, K. D., Brown, C., Cooke, T. D. V., Daniel, W., Gray, R., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331101 · Cited by 1,130
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C. H., Mitchell, P. G., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 970
Self-citationPham, T., van der Heijde, D. M. F. M., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M. C., Simon, L. S., Strand, V., Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849
Flagged first, then by citations
3 of the 129 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Atley, 1998, Matrix metalloproteinase-mediated release of immunoreactive telopeptides from cartilage type II collagen, Trans Orthop Res Soc, 23, 850
- Norlund, 1997, Markers of bone type I and cartilage type II collagen degradation in the Hartley guinea pig model of osteoarthritis, Trans Orthop Res, 22, 313
- Krasnokutsky, 2007, Peripheral blood leukocyte gene expression as biomarkers of disease in knee osteoarthritis (OA), Arthritis Rheum, 56
Cited by
Sorted by citations
Items 301–328 of 328
Stratified medicine: methods for evaluation of predictive biomarkers
Malottki, K. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Use of biomarkers for the purposes of diagnosis and drug discovery programs: where do we stand?
Ruíz‐Romero, C., & Blanco, F. J. (2013) · doi:10.2217/ebo.12.101
Biomarqueurs solubles dans l’arthrose
Eymard, F., & Chevalier, X. (2020) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2020.12.008
A Review on Novel Targets for Osteoarthritis Therapy
Srivastava, V., Srivastava, V., Tripathi, A. S., & Awasthi, H. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v67i01.001
McDonald, B. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.212037
Huard, J. (2021) · Orthopedics and Rheumatology Open Access Journal · doi:10.19080/oroaj.2021.17.555971
Li, Y., Kim, C., & Gandhi, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-19560-5_9
Pharmaceutical Biotechnology: The Role of Biotechnology in the Drug Discovery and Development
Tuda, F., Trpcevski, A., Imran, M., Sawhney, A., Ahmad, A., McCoy, J., & Tauseef, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98554-7_9
Epigenetic and Proteomic Signatures for Chronic Pain Patients after Total Knee Replacement
Giordano, R. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau451017562
Silva, J. A. P. D., Borges, L., Weimann, E., Dias, B. B., Faria, F. G., Salgado, B. F., de Freitas, P. B., Pithon‐Curi, T. C., & Hatanaka, E. (2023) · Translational Sports Medicine · doi:10.1155/2023/8852889
Magnetic resonance imaging and biochemical markers of cartilage disease
Singh, A., & Antony, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90597-8.00032-3
Diagnostic indications of knee joint fluid – current state ofknowledge
Turzański, D. (2023) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0054.1912
Predictive Factors for Total Knee Arthroplasty: An Observational Study
Iordache, S. A., Cursaru, A., Cretu, B. S., Niculae, C., Popa, M. I. G., Costache, M. A., Şerban, B., & Cîrstoiu, C. (2024) · Cureus · doi:10.7759/cureus.67519
Biomechanische und biochemische Veränderungen bei Degeneration und Früharthrose des Kniegelenks
Bartsch, A., Zindel-Geisseler, C., & Feucht, M. J. (2025) · Arthroskopie · doi:10.1007/s00142-025-00761-7
Aladağ, S., Demirdiş, İ., Gökçal, B., Fidan, B. B., Aktaş, B. E., Gizer, M., Kaplan, O., Yet, İ., Ekiz, M. Ş., Korkusuz, P., et al. (2025) · Tissue repair and reconstruction · doi:10.1007/978-981-96-3808-6_3
Yau, W. (2025) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000003647
Hummer, C. D., Huang, Y., & Sheehan, B. (2022) · Figshare · doi:10.6084/m9.figshare.19218423
Hummer, C. D., Huang, Y., & Sheehan, B. (2022) · Figshare · doi:10.6084/m9.figshare.19218417
Saxer, F., Jansen, G., Bierma-Zeinstra, S. M. A., Holzhauer, B., Demanse, D., Melnick, J., Greetham, D. V., Rall, T., Mesenbrink, P. G., & Schieker, M. (2025) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2025.12.021
Collins, J. E., Smith, K., Selzer, F., Katz, J. N., & Losina, E. (2026) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2026.02.005
Migliore, A., Iannarelli, N., Devito, A., Saporito, R., Saccone, L., Beriotto, I., Grassi, M., Cunego, E., Paglionico, A., & Tormenta, S. (2026) · Reumatismo · doi:10.4081/reumatismo.2026.1917
Analyse des micro-ARN dans le cadre de l'endométriose : apport clinico-biologique
Dabi, Y. (2023) · theses.fr (ABES) · doi:10.70675/ee221eccza824z4ddezbeb8z04286230c430
Smoking quitting promotes neuromuscular and cartilage recovery in knee osteoarthritis
Karim, A., Khan, I., Ahmad, F., & Qaisar, R. (2026) · European Journal of Applied Physiology · doi:10.1007/s00421-026-06265-y
Nelson, T., Elane, G. L., Barnhardt, E., & Hobbs, K. J. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1886084
Vescio, R. R., Fiordalisi, M. F., Ambrosio, L., Fiorentino, D., de Rinaldis, E., Giacomo, G. D., Russo, F., Denaro, V., Vadalà, G., & Papalia, R. (2026) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk11030343
Wang, B., Li, Y., Huang, J., Lian, Y., Gao, L., Zhang, S., Tang, S., Li, D., Yang, R., & Wu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955650
Fundamentals of osteoarthritis: Biomarkers
Kraus, V. B., & Karsdal, M. A. (2026) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2026.10.002
Self-citation
Metadata
- Authors
- Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegård, D., Ko, A., Lohmander, L. S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, A. R., Rousseau, J.-C., & Todman, M.
- Affiliations
- Duke Medical Center (US)
- Duke University (US)
- Amgen (United States) (US)
- University of Washington (US)
- Wyeth (US)
- Inserm (FR)
- Albert Einstein College of Medicine (US)
- University of Liège (BE)
- Lund University (SE)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Case Western Reserve University (US)
- McGill University (CA)
- Hospices Civils de Lyon (FR)
- Smith & Nephew (United Kingdom) (GB)
- Corresponding author
- Kraus, V.B.
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 19
- Issue
- 5
- Pages
- 515-542
- ISSN
- 1063-4584 (ISSN-L)
- PMC
- PMC3568396
- OpenAlex
- W2059670411
- Cited by
- 328
- References
- 129
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 15 · 2019: 20 · 2018: 13 · 2017: 23 · 2016: 24 · 2015: 35 · 2014: 25 · 2013: 26 · 2012: 24
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Osteoarthritis and Cartilage (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion)
- Funders
- National Institute on Aging (P30AG028716)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 50245, P01AR050245)
- National Center for Research Resources (UL1RR024128)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
- Keywords
- osteoarthritis, biomarkers, drug development, biomarker qualification, prognostic factors, treatment response monitoring, clinical trial outcome measures, drug discovery
- MeSH terms
- Clinical Trials as Topic, Humans, Osteoarthritis, Specimen Handling, Biomarkers, Treatment Outcome, Drug Monitoring, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
